Skip to main content

zoledronic acid

Generic: ZOLEDRONIC ACID·Brand: RECLAST, Reclast, ZOLEDRONIC, ZOLEDRONIC ACID, ZOMETA

zoledronic acid: 3 clinical trials tracked.

zoledronic acid evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about zoledronic acid, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trials (3)

Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia: An Exploratory Study

NCT07471516·Phase 1/Phase 2
Recruiting

Primary endpoint: Change in Hemoglobin Level From Baseline

Interventionalopen2 targetStarted 2026-02Completion 2027-081 site · ChinaInstitute of Hematology & Blood Diseases Hospital, China

A Phase Ib/II Trial of Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

NCT06374459·Phase 1/Phase 2
Recruiting

Primary endpoint: Number of participants with adverse events (Phase Ib only)

InterventionalRandomizedopen152 targetStarted 2025-01Completion 2032-053 sites · United StatesWashington University School of Medicine

Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment With Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy

NCT02516423·Phase 3
Terminated

Primary endpoint: Symptomatic Myeloma Progression Free-survival (PFS) Rate

InterventionalRandomizedopen11 targetStarted 2016-11Completion 2025-0950 sites · United StatesAlliance for Clinical Trials in Oncology